A Phase 1 Dose-Escalation Study of the Cladribine Added to CPX-351 in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) a Study of the Polish Adult Leukemia Group (AML-1/2018): Preliminary Results of the Dose Escalation Stage

Saved in:
Bibliographic Details
Published in:Blood 2022-11, Vol.140 (Supplement 1), p.6165-6166
Main Authors: Wierzbowska, Agnieszka, Pluta, Agnieszka, Stelmach, Piotr, Sobas, Marta Anna, Rybka, Justyna, Wróbel, Tomasz, Zarzycka, Ewa, Prejzner, Witold, Zaucha, Jan, Szczepaniak, Andrzej, Gil, Lidia, Giebel, Sebastian
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-163109